Systematic review and meta-analysis: a critical examination of the methodology

Author:

Martsevich S.Yu. S. Yu.1ORCID,Navasardyan A. R.2ORCID,Lobastov K. V.3ORCID,Mikaelyan M. V.4ORCID,Mikhaylenko E. V.5ORCID,Suvorov A. Yu.5ORCID,Schastlivtsev I. V.3ORCID,Dzhioeva O. N.1ORCID,Matveev V. V.6ORCID,Akimova E. S.7ORCID,Sytkov V. V.8ORCID,Dubar E.9ORCID,Drapkina O. M.1ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

2. National Medical Research Center for Therapy and Preventive Medicine; AO Bayer

3. Pirogov Russian National Research Medical University

4. AO Bayer

5. I. M. Sechenov First Moscow State Medical University

6. M. F.Vladimirsky Moscow Regional Research and Clinical Institute; Siemens healthineers LLC

7. A. I. Evdokimov Moscow State University of Medicine and Dentistry

8. A. I.Evdokimov Moscow State University of Medicine and Dentistry

9. S. S.Yudin City Clinical Hospita

Abstract

Nowadays, the pyramid of evidence is the main model of decision-making for healthcare professionals. According to this concept, data from randomized clinical trials (RCTs) are considered lower in hierarchy than data obtained from systematic reviews (SRs) and meta-analyses (MAs). However, it заменить на:is not established whether it is appropriate to rate large RCTs with hard endpoints lower than SRs and MAs that combine data from smaller RCTs of questionable quality, or even from prospective or retrospective observational studies. It is also important to consider that in addition to assessing the quality of the studies included in the SRs and MAs, it is necessary to assess the accuracy of the SRs and MAs themselves. If not rigorously conducted, they can also contain systematic errors, leading to increased risks of data manipulation. The publication covers the main stages and principles of preparing SRs and MAs, common types of systematic errors that can arise at each stage, and methods to minimize them. We believe that the tools, knowledge, and skills we offer will help practicing doctors and healthcare professionals critically assess the results obtained from SRs and MAs in terms of methodology and the mitigation of potential data manipulation risks.

Publisher

Silicea - Poligraf

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Is meta-analysis the "top of the evidence pyramid" in cardiology?;Cardiovascular Therapy and Prevention;2024-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3